WINKAST-250 INHALER
MRP: 765
Packaging: 120 MD
Pack Type: inhaler
Composition:
Fluticasone Propionate 250mg + Salmeterol 25mg
Indication:
Asthma, COPD
Description:
Fluticasone Propionate 250 mcg + Salmeterol 25 mcg is a fixed-dose combination inhaler designed for the long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD). Fluticasone is a potent corticosteroid that reduces inflammation in the airways, while Salmeterol is a long-acting beta-2 adrenergic agonist (LABA) that helps to relax the muscles in the airways, making breathing easier. This synergistic combination helps control symptoms, reduce flare-ups, and improve overall lung function.
Tags:
- Dual action: reduces inflammation and opens airways
- Helps prevent asthma attacks and COPD exacerbations
- Improves lung function and exercise tolerance
- Reduces hospitalizations due to chronic respiratory conditions
- Convenient twice-daily dosing
Usage Information
Dosage
Adults (Asthma/COPD): 1 inhalation twice daily or as prescribed Use with: Dry powder inhaler (DPI) or metered-dose inhaler (MDI) Administration tips: Shake well (for MDI) Rinse mouth after use to avoid oral thrush Use a spacer if needed (for MDI)
Side Effects
Hoarseness or throat irritation Oral thrush (fungal infection) Headache Palpitations Muscle cramps Cough Serious but rare: Allergic reactions, paradoxical bronchospasm, adrenal suppression (long-term high doses)
Contraindications
Known allergy to fluticasone, salmeterol, or excipients Not for relief of acute bronchospasm Use with caution in: Patients with active pulmonary infections Cardiovascular disorders Hyperthyroidism Diabetes mellitus
Availability
Fluticasone Salmeterol inhaler, asthma maintenance inhaler, COPD inhaler, steroid and LABA combination, Fluticasone 250 mcg Salmeterol 25 mcg, ICS LABA asthma medication